Teva Pharma B.V.
- C09 - Agentes activos sobre el sistema renina-angiotensina
- TELMISARTAN TEVA PHARMA tablet 20 mg
- TELMISARTAN TEVA PHARMA tablet 40 mg
- TELMISARTAN TEVA PHARMA tablet 80 mg
- VALSARTAN E IDROCLOROTIAZIDE TEVA PHARMA film-coated tablet 320 mg+12.5 mg
- VALSARTAN E IDROCLOROTIAZIDE TEVA PHARMA film-coated tablet 320 mg+25 mg
- L01 - Antineoplásicos
- CARBOPLATINO TEVA concentrate for solution for infusion 10 mg/ml
- ETOPOSIDE TEVA concentrate for solution for infusion 1 000 mg/50 ml
- ETOPOSIDE TEVA concentrate for solution for infusion 100 mg/5 ml
- ETOPOSIDE TEVA concentrate for solution for infusion 200 mg/10 ml
- ETOPOSIDE TEVA concentrate for solution for infusion 400 mg/20 ml
- ETOPOSIDE TEVA concentrate for solution for infusion 500 mg/25 ml
- N02 - Analgésicos
- GABAPENTIN TEVA PHARMA capsule, hard 100 mg
- GABAPENTIN TEVA PHARMA capsule, hard 300 mg
- GABAPENTIN TEVA PHARMA capsule, hard 400 mg
- N06 - Psicoanalépticos
- SERTRALINA TEVA PHARMA film-coated tablet 100 mg
- SERTRALINA TEVA PHARMA film-coated tablet 50 mg
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- BIRESP SPIROMAX inhalation powder 160 µg/dose+4.5 µg/dose
- BIRESP SPIROMAX inhalation powder 320 µg/dose+9 µg/dose
- BUDESONIDE FORMOTEROLO TEVA PHARMA B.V. inhalation powder 160 µg+4.5 µg
- BUDESONIDE FORMOTEROLO TEVA PHARMA B.V. inhalation powder 320 µg+9 µg
- DUORESP SPIROMAX inhalation powder 160 µg/dose+4.5 µg/dose
- DUORESP SPIROMAX inhalation powder 320 µg/dose+9 µg/dose